Loading…

Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation

The production of proinflammatory cytokines has been shown to play a critical role in a variety of retinal vascular diseases. Angiotensin II and VEGF have been implicated in the initiation of vascular inflammation and retinal vascular disease. However, detailed mechanisms of this process and interac...

Full description

Saved in:
Bibliographic Details
Published in:Investigative ophthalmology & visual science 2010-03, Vol.51 (3), p.1709-1718
Main Authors: Rojas, Modesto, Zhang, Wenbo, Lee, Dexter L, Romero, Maritza J, Nguyen, Doan T, Al-Shabrawey, Mohamed, Tsai, Nai-Tse, Liou, Gregory I, Brands, Michael W, Caldwell, Robert W, Caldwell, Ruth B
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c480t-2f615813f00b49b946ff56dca142d910456c339265024322d70f95bdeb7b6cec3
cites
container_end_page 1718
container_issue 3
container_start_page 1709
container_title Investigative ophthalmology & visual science
container_volume 51
creator Rojas, Modesto
Zhang, Wenbo
Lee, Dexter L
Romero, Maritza J
Nguyen, Doan T
Al-Shabrawey, Mohamed
Tsai, Nai-Tse
Liou, Gregory I
Brands, Michael W
Caldwell, Robert W
Caldwell, Ruth B
description The production of proinflammatory cytokines has been shown to play a critical role in a variety of retinal vascular diseases. Angiotensin II and VEGF have been implicated in the initiation of vascular inflammation and retinal vascular disease. However, detailed mechanisms of this process and interactions between inflammatory agonists and angiotensin II in promoting retinopathy are poorly understood. The present study was an investigation of the role of interleukin (IL)-6 in angiotensin II-induced retinopathy. Rats and IL-6-deficient and wild-type mice were treated with angiotensin II or IL-6, and their retinas were analyzed for leukocyte adhesion or for the expression and localization of VEGF or IL-6. Leukocyte adhesion was assayed by concanavalin A labeling. Vascular density was determined by morphometric analysis. NADPH oxidase activity was assayed by dihydroethidium imaging of superoxide. Intravitreal injection of angiotensin II caused increases in IL-6 mRNA and protein and in leukocyte adhesion to the retinal vessels. IL-6 protein was localized to CD11b-positive microglia and macrophage-like cells. Angiotensin II treatment stimulated increases in retinal levels of VEGF expression and NADPH oxidase activity, which were associated with increased surface area and remodeling of the retinal vessels. These effects were blocked by knocking out IL-6. Intravitreal IL-6 directly induced leukocyte adhesion in both wild-type and IL-6-deficient mice. The results indicate that IL-6 expression is essential for angiotensin II-induced increases in retinal VEGF expression, leukostasis, and vascular remodeling. The data suggest a critical role for IL-6 in mediating angiotensin II-induced retinal vascular inflammation and remodeling.
doi_str_mv 10.1167/iovs.09-3375
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2868419</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19834028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-2f615813f00b49b946ff56dca142d910456c339265024322d70f95bdeb7b6cec3</originalsourceid><addsrcrecordid>eNpVkE1r4zAQhsXSsk3bvfVcfOqpzs7oy9alUPppCCyU7V6FLEuJii0Xy2nYf1-HhH6cZmCe9x14CDlDmCPK4nfo39IcVM5YIX6QGQpBc1GU7IDMALnMgQM_IscpvQBQRAo_yRGqknGg5YzcPvWty3qfVYtcZiFm13EZ-tHFNO1VlVexWVvXZE9uDNG02T-T7Lo1Q1ZF35quM2Po4yk59KZN7td-npDn-7u_N4_54s9DdXO9yC0vYcyplyhKZB6g5qpWXHovZGMNctooBC6kZUxRKYByRmlTgFeiblxd1NI6y07I1a73dV13rrEujoNp9esQOjP8170J-vslhpVe9m-alrLkqKaCy12BHfqUBuc_sgh6a1NvbWpQemtzws-__vuE9_om4GIHrMJytQmD06kzbTvhqDebjUDNNBag2Ds30X2-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation</title><source>PubMed Central</source><creator>Rojas, Modesto ; Zhang, Wenbo ; Lee, Dexter L ; Romero, Maritza J ; Nguyen, Doan T ; Al-Shabrawey, Mohamed ; Tsai, Nai-Tse ; Liou, Gregory I ; Brands, Michael W ; Caldwell, Robert W ; Caldwell, Ruth B</creator><creatorcontrib>Rojas, Modesto ; Zhang, Wenbo ; Lee, Dexter L ; Romero, Maritza J ; Nguyen, Doan T ; Al-Shabrawey, Mohamed ; Tsai, Nai-Tse ; Liou, Gregory I ; Brands, Michael W ; Caldwell, Robert W ; Caldwell, Ruth B</creatorcontrib><description>The production of proinflammatory cytokines has been shown to play a critical role in a variety of retinal vascular diseases. Angiotensin II and VEGF have been implicated in the initiation of vascular inflammation and retinal vascular disease. However, detailed mechanisms of this process and interactions between inflammatory agonists and angiotensin II in promoting retinopathy are poorly understood. The present study was an investigation of the role of interleukin (IL)-6 in angiotensin II-induced retinopathy. Rats and IL-6-deficient and wild-type mice were treated with angiotensin II or IL-6, and their retinas were analyzed for leukocyte adhesion or for the expression and localization of VEGF or IL-6. Leukocyte adhesion was assayed by concanavalin A labeling. Vascular density was determined by morphometric analysis. NADPH oxidase activity was assayed by dihydroethidium imaging of superoxide. Intravitreal injection of angiotensin II caused increases in IL-6 mRNA and protein and in leukocyte adhesion to the retinal vessels. IL-6 protein was localized to CD11b-positive microglia and macrophage-like cells. Angiotensin II treatment stimulated increases in retinal levels of VEGF expression and NADPH oxidase activity, which were associated with increased surface area and remodeling of the retinal vessels. These effects were blocked by knocking out IL-6. Intravitreal IL-6 directly induced leukocyte adhesion in both wild-type and IL-6-deficient mice. The results indicate that IL-6 expression is essential for angiotensin II-induced increases in retinal VEGF expression, leukostasis, and vascular remodeling. The data suggest a critical role for IL-6 in mediating angiotensin II-induced retinal vascular inflammation and remodeling.</description><identifier>ISSN: 0146-0404</identifier><identifier>ISSN: 1552-5783</identifier><identifier>EISSN: 1552-5783</identifier><identifier>DOI: 10.1167/iovs.09-3375</identifier><identifier>PMID: 19834028</identifier><language>eng</language><publisher>United States: ARVO</publisher><subject>Angiotensin II - pharmacology ; Animals ; Blotting, Western ; Cell Adhesion ; Enzyme-Linked Immunosorbent Assay ; Interleukin-6 - pharmacology ; Interleukin-6 - physiology ; Leukocytes - metabolism ; Leukostasis - chemically induced ; Leukostasis - prevention &amp; control ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Microscopy, Confocal ; NADPH Oxidases - metabolism ; Rats ; Rats, Sprague-Dawley ; Retinal Vasculitis - chemically induced ; Retinal Vasculitis - metabolism ; Retinal Vessels - drug effects ; Retinal Vessels - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - metabolism ; Superoxides - metabolism ; Up-Regulation ; Vascular Endothelial Growth Factor A - metabolism ; Vasoconstrictor Agents - pharmacology</subject><ispartof>Investigative ophthalmology &amp; visual science, 2010-03, Vol.51 (3), p.1709-1718</ispartof><rights>Copyright © Association for Research in Vision and Ophthalmology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-2f615813f00b49b946ff56dca142d910456c339265024322d70f95bdeb7b6cec3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868419/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868419/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19834028$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rojas, Modesto</creatorcontrib><creatorcontrib>Zhang, Wenbo</creatorcontrib><creatorcontrib>Lee, Dexter L</creatorcontrib><creatorcontrib>Romero, Maritza J</creatorcontrib><creatorcontrib>Nguyen, Doan T</creatorcontrib><creatorcontrib>Al-Shabrawey, Mohamed</creatorcontrib><creatorcontrib>Tsai, Nai-Tse</creatorcontrib><creatorcontrib>Liou, Gregory I</creatorcontrib><creatorcontrib>Brands, Michael W</creatorcontrib><creatorcontrib>Caldwell, Robert W</creatorcontrib><creatorcontrib>Caldwell, Ruth B</creatorcontrib><title>Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation</title><title>Investigative ophthalmology &amp; visual science</title><addtitle>Invest Ophthalmol Vis Sci</addtitle><description>The production of proinflammatory cytokines has been shown to play a critical role in a variety of retinal vascular diseases. Angiotensin II and VEGF have been implicated in the initiation of vascular inflammation and retinal vascular disease. However, detailed mechanisms of this process and interactions between inflammatory agonists and angiotensin II in promoting retinopathy are poorly understood. The present study was an investigation of the role of interleukin (IL)-6 in angiotensin II-induced retinopathy. Rats and IL-6-deficient and wild-type mice were treated with angiotensin II or IL-6, and their retinas were analyzed for leukocyte adhesion or for the expression and localization of VEGF or IL-6. Leukocyte adhesion was assayed by concanavalin A labeling. Vascular density was determined by morphometric analysis. NADPH oxidase activity was assayed by dihydroethidium imaging of superoxide. Intravitreal injection of angiotensin II caused increases in IL-6 mRNA and protein and in leukocyte adhesion to the retinal vessels. IL-6 protein was localized to CD11b-positive microglia and macrophage-like cells. Angiotensin II treatment stimulated increases in retinal levels of VEGF expression and NADPH oxidase activity, which were associated with increased surface area and remodeling of the retinal vessels. These effects were blocked by knocking out IL-6. Intravitreal IL-6 directly induced leukocyte adhesion in both wild-type and IL-6-deficient mice. The results indicate that IL-6 expression is essential for angiotensin II-induced increases in retinal VEGF expression, leukostasis, and vascular remodeling. The data suggest a critical role for IL-6 in mediating angiotensin II-induced retinal vascular inflammation and remodeling.</description><subject>Angiotensin II - pharmacology</subject><subject>Animals</subject><subject>Blotting, Western</subject><subject>Cell Adhesion</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Interleukin-6 - pharmacology</subject><subject>Interleukin-6 - physiology</subject><subject>Leukocytes - metabolism</subject><subject>Leukostasis - chemically induced</subject><subject>Leukostasis - prevention &amp; control</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Microscopy, Confocal</subject><subject>NADPH Oxidases - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Retinal Vasculitis - chemically induced</subject><subject>Retinal Vasculitis - metabolism</subject><subject>Retinal Vessels - drug effects</subject><subject>Retinal Vessels - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - metabolism</subject><subject>Superoxides - metabolism</subject><subject>Up-Regulation</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>Vasoconstrictor Agents - pharmacology</subject><issn>0146-0404</issn><issn>1552-5783</issn><issn>1552-5783</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNpVkE1r4zAQhsXSsk3bvfVcfOqpzs7oy9alUPppCCyU7V6FLEuJii0Xy2nYf1-HhH6cZmCe9x14CDlDmCPK4nfo39IcVM5YIX6QGQpBc1GU7IDMALnMgQM_IscpvQBQRAo_yRGqknGg5YzcPvWty3qfVYtcZiFm13EZ-tHFNO1VlVexWVvXZE9uDNG02T-T7Lo1Q1ZF35quM2Po4yk59KZN7td-npDn-7u_N4_54s9DdXO9yC0vYcyplyhKZB6g5qpWXHovZGMNctooBC6kZUxRKYByRmlTgFeiblxd1NI6y07I1a73dV13rrEujoNp9esQOjP8170J-vslhpVe9m-alrLkqKaCy12BHfqUBuc_sgh6a1NvbWpQemtzws-__vuE9_om4GIHrMJytQmD06kzbTvhqDebjUDNNBag2Ds30X2-</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Rojas, Modesto</creator><creator>Zhang, Wenbo</creator><creator>Lee, Dexter L</creator><creator>Romero, Maritza J</creator><creator>Nguyen, Doan T</creator><creator>Al-Shabrawey, Mohamed</creator><creator>Tsai, Nai-Tse</creator><creator>Liou, Gregory I</creator><creator>Brands, Michael W</creator><creator>Caldwell, Robert W</creator><creator>Caldwell, Ruth B</creator><general>ARVO</general><general>Association for Research in Vision and Ophthalmology, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20100301</creationdate><title>Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation</title><author>Rojas, Modesto ; Zhang, Wenbo ; Lee, Dexter L ; Romero, Maritza J ; Nguyen, Doan T ; Al-Shabrawey, Mohamed ; Tsai, Nai-Tse ; Liou, Gregory I ; Brands, Michael W ; Caldwell, Robert W ; Caldwell, Ruth B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-2f615813f00b49b946ff56dca142d910456c339265024322d70f95bdeb7b6cec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Angiotensin II - pharmacology</topic><topic>Animals</topic><topic>Blotting, Western</topic><topic>Cell Adhesion</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Interleukin-6 - pharmacology</topic><topic>Interleukin-6 - physiology</topic><topic>Leukocytes - metabolism</topic><topic>Leukostasis - chemically induced</topic><topic>Leukostasis - prevention &amp; control</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Microscopy, Confocal</topic><topic>NADPH Oxidases - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Retinal Vasculitis - chemically induced</topic><topic>Retinal Vasculitis - metabolism</topic><topic>Retinal Vessels - drug effects</topic><topic>Retinal Vessels - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - metabolism</topic><topic>Superoxides - metabolism</topic><topic>Up-Regulation</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>Vasoconstrictor Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rojas, Modesto</creatorcontrib><creatorcontrib>Zhang, Wenbo</creatorcontrib><creatorcontrib>Lee, Dexter L</creatorcontrib><creatorcontrib>Romero, Maritza J</creatorcontrib><creatorcontrib>Nguyen, Doan T</creatorcontrib><creatorcontrib>Al-Shabrawey, Mohamed</creatorcontrib><creatorcontrib>Tsai, Nai-Tse</creatorcontrib><creatorcontrib>Liou, Gregory I</creatorcontrib><creatorcontrib>Brands, Michael W</creatorcontrib><creatorcontrib>Caldwell, Robert W</creatorcontrib><creatorcontrib>Caldwell, Ruth B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Investigative ophthalmology &amp; visual science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rojas, Modesto</au><au>Zhang, Wenbo</au><au>Lee, Dexter L</au><au>Romero, Maritza J</au><au>Nguyen, Doan T</au><au>Al-Shabrawey, Mohamed</au><au>Tsai, Nai-Tse</au><au>Liou, Gregory I</au><au>Brands, Michael W</au><au>Caldwell, Robert W</au><au>Caldwell, Ruth B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation</atitle><jtitle>Investigative ophthalmology &amp; visual science</jtitle><addtitle>Invest Ophthalmol Vis Sci</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>51</volume><issue>3</issue><spage>1709</spage><epage>1718</epage><pages>1709-1718</pages><issn>0146-0404</issn><issn>1552-5783</issn><eissn>1552-5783</eissn><abstract>The production of proinflammatory cytokines has been shown to play a critical role in a variety of retinal vascular diseases. Angiotensin II and VEGF have been implicated in the initiation of vascular inflammation and retinal vascular disease. However, detailed mechanisms of this process and interactions between inflammatory agonists and angiotensin II in promoting retinopathy are poorly understood. The present study was an investigation of the role of interleukin (IL)-6 in angiotensin II-induced retinopathy. Rats and IL-6-deficient and wild-type mice were treated with angiotensin II or IL-6, and their retinas were analyzed for leukocyte adhesion or for the expression and localization of VEGF or IL-6. Leukocyte adhesion was assayed by concanavalin A labeling. Vascular density was determined by morphometric analysis. NADPH oxidase activity was assayed by dihydroethidium imaging of superoxide. Intravitreal injection of angiotensin II caused increases in IL-6 mRNA and protein and in leukocyte adhesion to the retinal vessels. IL-6 protein was localized to CD11b-positive microglia and macrophage-like cells. Angiotensin II treatment stimulated increases in retinal levels of VEGF expression and NADPH oxidase activity, which were associated with increased surface area and remodeling of the retinal vessels. These effects were blocked by knocking out IL-6. Intravitreal IL-6 directly induced leukocyte adhesion in both wild-type and IL-6-deficient mice. The results indicate that IL-6 expression is essential for angiotensin II-induced increases in retinal VEGF expression, leukostasis, and vascular remodeling. The data suggest a critical role for IL-6 in mediating angiotensin II-induced retinal vascular inflammation and remodeling.</abstract><cop>United States</cop><pub>ARVO</pub><pmid>19834028</pmid><doi>10.1167/iovs.09-3375</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0146-0404
ispartof Investigative ophthalmology & visual science, 2010-03, Vol.51 (3), p.1709-1718
issn 0146-0404
1552-5783
1552-5783
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2868419
source PubMed Central
subjects Angiotensin II - pharmacology
Animals
Blotting, Western
Cell Adhesion
Enzyme-Linked Immunosorbent Assay
Interleukin-6 - pharmacology
Interleukin-6 - physiology
Leukocytes - metabolism
Leukostasis - chemically induced
Leukostasis - prevention & control
Mice
Mice, Inbred C57BL
Mice, Knockout
Microscopy, Confocal
NADPH Oxidases - metabolism
Rats
Rats, Sprague-Dawley
Retinal Vasculitis - chemically induced
Retinal Vasculitis - metabolism
Retinal Vessels - drug effects
Retinal Vessels - metabolism
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - metabolism
Superoxides - metabolism
Up-Regulation
Vascular Endothelial Growth Factor A - metabolism
Vasoconstrictor Agents - pharmacology
title Role of IL-6 in Angiotensin II-Induced Retinal Vascular Inflammation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A04%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20IL-6%20in%20Angiotensin%20II-Induced%20Retinal%20Vascular%20Inflammation&rft.jtitle=Investigative%20ophthalmology%20&%20visual%20science&rft.au=Rojas,%20Modesto&rft.date=2010-03-01&rft.volume=51&rft.issue=3&rft.spage=1709&rft.epage=1718&rft.pages=1709-1718&rft.issn=0146-0404&rft.eissn=1552-5783&rft_id=info:doi/10.1167/iovs.09-3375&rft_dat=%3Cpubmed_cross%3E19834028%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c480t-2f615813f00b49b946ff56dca142d910456c339265024322d70f95bdeb7b6cec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19834028&rfr_iscdi=true